Sven Bischoff

1.9k total citations
23 papers, 955 citations indexed

About

Sven Bischoff is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sven Bischoff has authored 23 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sven Bischoff's work include Pancreatic and Hepatic Oncology Research (12 papers), Renal cell carcinoma treatment (4 papers) and Pancreatitis Pathology and Treatment (4 papers). Sven Bischoff is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Renal cell carcinoma treatment (4 papers) and Pancreatitis Pathology and Treatment (4 papers). Sven Bischoff collaborates with scholars based in Germany and Switzerland. Sven Bischoff's co-authors include Hanno Riess, Uwe Pelzer, Helmut Oettle, Jens Stieler, Bernd Dörken, Marianne Sinn, Gerhard Heil, Matthias Mölle, Tim F. Greten and Jana K. Striefler and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Sven Bischoff

22 papers receiving 944 citations

Peers

Countries citing papers authored by Sven Bischoff

Since Specialization

Citations

This map shows the geographic impact of Sven Bischoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Bischoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Bischoff more than expected).

Fields of papers citing papers by Sven Bischoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Bischoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Bischoff. The network helps show where Sven Bischoff may publish in the future.

Co-authorship network of co-authors of Sven Bischoff

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Bischoff. A scholar is included among the top collaborators of Sven Bischoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Bischoff. Sven Bischoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phasic left atrial strain to predict worsening of diastolic function: Results from the prospective Berlin Female Risk Evaluation follow-up trial 2023 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), (unknown), (unknown), Ute Seeland, (unknown), Sven Bischoff, (unknown), Henryk Dreger, Karl Stangl, Vera Regitz‐Zagrosek, Ulf Landmesser, Fabian Knebel, Verena Stangl	8
2	Impact of body mass index on worsening of diastolic function and impairment of left atrial strain in the general female urban population: a subanalysis of the Berlin female risk evaluation echocardiography follow-up study 2023 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), (unknown), (unknown), Ute Seeland, (unknown), Sven Bischoff, (unknown), Henryk Dreger, Karl Stangl, Vera Regitz‐Zagrosek, Ulf Landmesser, Fabian Knebel, Verena Stangl, (unknown)	1
3	Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma – A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials 2021 ·European Journal of Cancer ·Annika Kurreck, (unknown), Dominik Paul Modest, Jana K. Striefler, Marcus Bahra, Sven Bischoff, Uwe Pelzer, Helmut Oettle, Stephan Krüger, Hanno Riess, Marianne Sinn	5
4	Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study 2021 ·Oncology Research and Treatment ·Robert Klamroth, Marianne Sinn, (unknown), Sven Bischoff, (unknown), (unknown), (unknown), Piet Habbel, Maike de Wit, E. Späth‐Schwalbe, Christian Schölz, Hanno Riess	3
5	Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study 2021 ·Frontiers in Oncology ·Jana K. Striefler, Hanno Riess, Philipp Lohneis, Sven Bischoff, Annika Kurreck, Dominik Paul Modest, Marcus Bahra, Helmut Oettle, Marianne Sinn, (unknown), Carsten Denkert, Sebastian Stintzing, Bruno V. Sinn, Uwe Pelzer	30
6	Endotypes of chronic rhinosinusitis with nasal polyps with and without NSAID – intolerance 2020 ·Rhinology Journal ·(unknown), Sven Bischoff, Alan Valaperti, Kristian Ikenberg, Jerzy Starzyk, Sara Magnusson Bucher, Lucas M. Bachmann, Michael Soyka	12
7	Trigeminal endonasal perception – an outcome predictor for septoplasty 2020 ·Rhinology Journal ·Sven Bischoff, Sophia C. Poletti, (unknown), (unknown), (unknown), A. Dreher, Cezmi A. Akdiş, Michael Soyka	10
8	CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results 2020 ·European Journal of Cancer ·M. Sinn, Torsten Liersch, Hanno Riess, Klaus Gellert, P. Stübs, (unknown), Frank Lammert, Georg Maschmeyer, Wolf O. Bechstein, Michael Bitzer, Claudio Denzlinger, Ralf‐Dieter Hofheinz, Udo Lindig, Michael Ghadimi, Axel Hinke, Jana K. Striefler, Uwe Pelzer, Sven Bischoff, Marcus Bahra, Helmut Oettle	22
9	Longstanding diplopia after ethmoidal artery ligation for epistaxis 2019 ·European Archives of Oto-Rhino-Laryngology ·Sven Bischoff, Christina Gerth‐Kahlert, David Holzmann, Michael Soyka	0
10	Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma 2018 ·British Journal of Cancer ·Philipp Lohneis, Marianne Sinn, Fritz Klein, Sven Bischoff, Jana K. Striefler, (unknown), Bruno V. Sinn, Uwe Pelzer, Helmut Oettle, Hanno Riess, Carsten Denkert, Hendrik Bläker, (unknown)	33
11	TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study 2017 ·Annals of Oncology ·M. Sinn, Jan Budczies, Frédérik Damm, Philipp Lohneis, Rosa Schmuck, Denise Treue, Jana K. Striefler, Marcus Bahra, Uwe Pelzer, (unknown), Hendrik Bläker, Sven Bischoff, Helmut Oettle, Carsten Denkert, Hanno Riess, (unknown)	3
12	Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma 2017 ·European Journal of Cancer ·Philipp Lohneis, Marianne Sinn, Sven Bischoff, (unknown), Uwe Pelzer, (unknown), Marcus Bahra, Bruno V. Sinn, Carsten Denkert, Helmut Oettle, Hendrik Bläker, Hanno Riess, Korinna Jöhrens, Jana K. Striefler	67
13	Second-Line Treatment in Pancreatic Cancer Patients 2015 ·Pancreas ·Marianne Sinn, (unknown), Jana K. Striefler, Sven Bischoff, Nóra Schweitzer, Uwe Pelzer, Bernd Dörken, Hanno Riess, Jens Stieler	18
14	Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial 2015 ·Journal of Clinical Oncology ·Uwe Pelzer, Bernhard Opitz, G. Deutschinoff, Martina Stauch, P Reitzig, S. Hahnfeld, Lothar Müller, (unknown), Jens Stieler, Marianne Sinn, Timm Denecke, Sven Bischoff, Helmut Oettle, Bernd Dörken, Hanno Riess	187
15	SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study 2014 ·Annals of Oncology ·M. Sinn, (unknown), Jana K. Striefler, Judith Lindner, Jens Stieler, Philipp Lohneis, Sven Bischoff, (unknown), Uwe Pelzer, Marcus Bahra, Manfred Dietel, Bernd Dörken, Helmut Oettle, Hanno Riess, Carsten Denkert	63
16	Does long-term survival in patients with pancreatic cancer really exist?-Results from the CONKO-001 study 2013 ·Journal of Surgical Oncology ·Marianne Sinn, Jana K. Striefler, Bruno V. Sinn, (unknown), Sven Bischoff, Jens Stieler, Uwe Pelzer, Marcus Bahra, P. Neuhaus, Bernd Dörken, Carsten Denkert, Hanno Riess, Helmut Oettle	36
17	Biliary Tract Cancer: A Survey Regarding the Current Oncological Daily Care Practice in Germany 2012 ·Onkologie ·Marianne Sinn, Sven Bischoff, Oliver Nehls, Uwe Pelzer, Fritz von Weizsäcker, Stefan Kubicka, Jens Stieler, Karel Caca, Hanno Riess	1
18	Semiconducting properties of polypyrrole films in aqueous solution 1999 ·Journal of Solid State Electrochemistry ·U. Rammelt, Sven Bischoff, Renate Schulze, (unknown), (unknown), Waldfried Plieth	29
19	Perioperative Changes in Body Composition and Metabolism in Patients with Colorectal Cancer according to Tumor Stage 1996 ·Oncology Research and Treatment ·(unknown), R. Raab, O. Selberg, Sven Bischoff, (unknown), Johannes Müller, (unknown)	2
20	Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. 1996 ·PubMed ·Volker Groß, T. Andus, I. Caesar, Sven Bischoff, H. Lochs, A Tromm, (unknown), (unknown), Audrey Weber, M Gierend, K. Ewe, J Schölmerich	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact